Suchergebnisse - "Hou, Ming"

PubPharm (43)

1

Evaluating Recurrence Risk in Patients Undergoing Breast-conserving Surgery Using E-cadherin Staining as a Biomarker

enthalten in: In vivo (Athens, Greece) | 2024

von Kao, C. | Chen, C. | Chu, W. | +5

2

Prognostic Nutritional Index as a Prognostic Factor for Very Early-Stage Hepatocellular Carcinoma

enthalten in: Clinical and translational gastroenterology | 2024

von Ho, C. | Chia-Hui Tan, E. | Lee, P. | +6

3

The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels

enthalten in: Journal of the Formosan Medical Association = Taiwan yi zhi | 2023

von Fu, C. | Wei, C. | Chu, C. | +7

4

Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer

enthalten in: International journal of molecular sciences | 2023

von Kuo, C. | Moi, S. | Hou, M. | +2

5

PD‑L1/PD‑1 blockade in breast cancer : The immunotherapy era (Review)

enthalten in: Oncology reports | 2021

von Li, C. | Lin, L. | Hou, M. | +1

6

Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients

enthalten in: PloS one | 2021

von Wu, P. | Hsieh, Y. | Lee, K. | +3

7

Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab

enthalten in: EBioMedicine | 2020

von Shi, Y. | Su, H. | Song, Y. | +18

8

Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics

enthalten in: Life sciences | 2019

von Ou-Yang, F. | Pan, M. | Chang, S. | +5

9

A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2019

von Lee, I. | Hung, Y. | Liu, C. | +8

10

Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2019

von Ho, S. | Hsu, C. | Liu, P. | +5

1
2
3
4
5
Nächster »
[5]